23andMe’s Struggles: From DNA Testing Giant to Financial Uncertainty and Data Privacy Concerns
Once celebrated as a revolutionary player in the DNA-testing market, 23andMe now faces significant challenges, as its stock value has plummeted from remarkable highs. This firm, known for its ancestry and health insights through DNA analysis, has shifted from being a tech darling with a value surpassing even some major brands to now barely holding…